We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current TELO market cap is 161.08M. The company's latest EPS is USD -0.4415 and P/E is -11.76.
Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | ||
Total Revenue | 0 | 0 | 0 | 0 |
Operating Income | -1.08M | -1.92M | -1.47M | -5.95M |
Net Income | -9.33M | -6.26M | -1.45M | -5.93M |
Year End 31 December 2023 | 2021 | 2022 | 2023 |
---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 0 | 0 | 0 |
Operating Income | -138k | -854k | -3.94M |
Net Income | -138k | -854k | -13.07M |
Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | ||
Total Assets | 4.77M | 3.5M | 2.1M | 1.04M |
Total Liabilities | 1.34M | 486k | 534k | 600k |
Total Equity | 3.44M | 3.02M | 1.57M | 442k |
Year End 31 December 2023 | 2021 | 2022 | 2023 |
---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 0 | 49k | 4.77M |
Total Liabilities | 138k | 986k | 1.34M |
Total Equity | -138k | -937k | 3.44M |
Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | ||
Operating | -3.86M | -1.94M | -3.46M | -4.46M |
Investing | N/A | N/A | N/A | N/A |
Financing | 3.86M | 5.21M | 5.35M | 5.3M |
Year End 31 December 2023 | 2021 | 2022 | 2023 |
---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | |
Operating | -119k | -469k | -3.86M |
Investing | N/A | N/A | N/A |
Financing | 119k | 470k | 3.86M |
Market Cap | 161.08M |
Price to Earnings Ratio | -11.76 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 0 |
Price to Book Ratio | 44.7 |
Dividend Yield | - |
Shares Outstanding | 29.61M |
Average Volume (1 week) | 283.38k |
Average Volume (1 Month) | 261.64k |
52 Week Change | -22.29% |
52 Week High | 20.72 |
52 Week Low | 3.11 |
Spread (Intraday) | 3.27 (42.08%) |
Company Name | Telomir Pharmaceuticals Inc |
Address |
900 west platt street, suite 200 tampa, florida 33606 |
Website | https://www.telomirpharma.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions